| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |